JP2008528696A5 - - Google Patents

Download PDF

Info

Publication number
JP2008528696A5
JP2008528696A5 JP2007554228A JP2007554228A JP2008528696A5 JP 2008528696 A5 JP2008528696 A5 JP 2008528696A5 JP 2007554228 A JP2007554228 A JP 2007554228A JP 2007554228 A JP2007554228 A JP 2007554228A JP 2008528696 A5 JP2008528696 A5 JP 2008528696A5
Authority
JP
Japan
Prior art keywords
lipid
complex
serine
group
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007554228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008528696A (ja
Filing date
Publication date
Priority claimed from US11/049,134 external-priority patent/US7351688B2/en
Application filed filed Critical
Publication of JP2008528696A publication Critical patent/JP2008528696A/ja
Publication of JP2008528696A5 publication Critical patent/JP2008528696A5/ja
Pending legal-status Critical Current

Links

JP2007554228A 2005-02-02 2006-02-02 低免疫原性のタンパク質製剤のための組成物および方法 Pending JP2008528696A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/049,134 US7351688B2 (en) 2003-02-05 2005-02-02 Compositions and methods for less immunogenic protein formulations
PCT/US2006/003779 WO2006084095A1 (en) 2005-02-02 2006-02-02 Compositions and methods for less immunogenic protein formulations

Publications (2)

Publication Number Publication Date
JP2008528696A JP2008528696A (ja) 2008-07-31
JP2008528696A5 true JP2008528696A5 (enExample) 2009-04-02

Family

ID=36777576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007554228A Pending JP2008528696A (ja) 2005-02-02 2006-02-02 低免疫原性のタンパク質製剤のための組成物および方法

Country Status (7)

Country Link
US (1) US7351688B2 (enExample)
EP (1) EP1858532A4 (enExample)
JP (1) JP2008528696A (enExample)
AU (1) AU2006210609A1 (enExample)
CA (1) CA2596280A1 (enExample)
NZ (1) NZ560327A (enExample)
WO (1) WO2006084095A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007117469A2 (en) 2006-03-30 2007-10-18 The Research Foundation Of State University Of New York Compositions of less immunogenic and long-circulating protein-lipid complexes
EP1988101A1 (en) * 2007-05-04 2008-11-05 Novo Nordisk A/S Improvement of factor VIII polypeptide titers in cell cultures
US20120164189A1 (en) * 2009-07-07 2012-06-28 Balu-Iyer Sathy V Lipidic Compositions for Induction of Immune Tolerance
US10617640B2 (en) * 2009-07-07 2020-04-14 The Research Foundation For The State University Of New York Phosphoserine containing compositions for immune tolerance induction
WO2011016043A2 (en) * 2009-08-06 2011-02-10 Technion Research & Development Foundation Ltd. Antibiotic drug delivery and potentiation
US10138290B2 (en) 2010-10-05 2018-11-27 Novo Nordisk Healthcare Ag Process for protein production
JP6347743B2 (ja) * 2011-05-05 2018-06-27 マティナス バイオファーマ ナノテクノロジーズ,インコーポレーテッド コクリエート組成物およびその製造および使用方法
US10064922B2 (en) * 2011-10-06 2018-09-04 The Research Foundation For The State University Of New York Compositions and methods for immune tolerance induction
WO2015048145A1 (en) 2013-09-24 2015-04-02 The Research Foundation For The State University Of New York Compositions and methods for reducing antigen-specific immunogenicity
US11083782B2 (en) * 2016-04-05 2021-08-10 The Research Foundation For The State University Of New York Phosphoserine containing compositions for immune tolerance induction

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127502A (en) 1977-06-10 1978-11-28 Eastman Kodak Company Stabilizers for reconstituted, lyophilized samples
US4795806A (en) 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
US5580856A (en) 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
WO1998048837A1 (en) 1997-04-30 1998-11-05 Enzon, Inc. Polyalkylene oxide-modified single chain polypeptides
SE513221C2 (sv) * 1998-04-17 2000-07-31 Net Insight Ab Förfarande och anordning för allokering av tidluckor till en kanal i ett kretskopplat tidsmultiplexerat nät
MXPA00010241A (es) 1998-04-27 2004-09-06 Opperbas Holding Bv Composicion farmaceutica que comprende el factor viii y liposomas neutrales..
US20020132982A1 (en) * 2000-11-30 2002-09-19 Balasubramanian Sathyamangalam V. AHF associated dispersion system and method for preparation
ZA200305980B (en) 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
WO2003013245A1 (en) 2001-08-07 2003-02-20 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
US20040229793A1 (en) 2003-02-05 2004-11-18 Balasubramanian Sathyamangalam V. Compositions and methods for less immunogenic protein formulations

Similar Documents

Publication Publication Date Title
Zuo et al. Current perspectives in pulmonary surfactant—inhibition, enhancement and evaluation
JP2015519383A5 (enExample)
JP2004529163A5 (enExample)
KR100381449B1 (ko) 에테르지질리포좀과이들의제약학적용도
ES2762224T3 (es) Liposomas que comprenden lípidos conjugados con polímero y usos relacionados
JP2018184470A5 (enExample)
CA2486127C (en) Method of treating dyslipidemic disorders
Dass et al. Apolipoprotein A‐I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis. A review
JP2015515992A5 (enExample)
Rakotomanga et al. Hexadecylphosphocholine interaction with lipid monolayers
JP2008528696A5 (enExample)
JP2019023243A5 (enExample)
JP2016505545A5 (enExample)
JP2008538105A5 (enExample)
NL8002097A (nl) Parenteraal toedienbare stabiele geneesmiddel- oplossingen.
PT1863448E (pt) Novas composições de lipossomas
CA2427467A1 (en) Sn-38 lipid complexes and methods of use
ATE469660T1 (de) Gasgefüllte mikrovesikel mit polymer- modifizierten lipiden
JP2007515471A5 (enExample)
US20100184964A1 (en) Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease
JP2010505937A5 (enExample)
ES2290333T3 (es) Composiciones de vehiculos lipidicos y metodos para la retencion mejorada de farmacos.
WO2003061666A1 (en) Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases
JP2005505521A5 (enExample)
JP2008519064A5 (enExample)